Frankfurt-am-Main, Germany

Klaus W Hummel


Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 39(Granted Patents)


Location History:

  • Humbololsterass, DE (1988)
  • Frankfurt-am-Main, DE (1982 - 1991)

Company Filing History:


Years Active: 1982-1991

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Klaus W. Hummel: Innovator in Antitumor and Antiviral Therapeutics

Introduction

Klaus W. Hummel is a prominent inventor based in Frankfurt-am-Main, Germany, known for his significant contributions to the fields of pharmaceuticals and therapeutics. With a total of six patents to his name, Hummel has focused on developing innovative compounds that offer promising solutions for combating tumors and viral infections.

Latest Patents

Hummel's latest patents include groundbreaking inventions titled "Xanthates as antitumor agents," which feature novel antitumor and antiviral xanthate compounds. These patents disclose a process for producing these compounds, pharmaceutical compositions that contain them, and methods for combating viruses and tumors with these innovative agents. Another notable patent is "Antiviral and antitumor xanthate pharmaceutical compositions." This invention pertains to compositions that control viruses and tumors by incorporating an adjuvant that enhances the antiviral and antitumor activity of xanthates. The adjuvant is characterized by its ionic nature, preferably an anionic compound, with specific structural features to maximize efficacy.

Career Highlights

Throughout his career, Klaus W. Hummel has worked with reputable companies, including Merz + Co. GmbH & Co. and Merz & Co. His dedication to research and development in pharmaceutical sciences has led to significant advancements, particularly in the innovative use of xanthate compounds for therapeutic purposes.

Collaborations

Hummel has collaborated with talented individuals in his field, notably Arthur Scherm and Dezsoe Peteri. These collaborations have fostered a collaborative environment for innovation, further enhancing the quality and impact of their research efforts.

Conclusion

Klaus W. Hummel's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents reflect a commitment to addressing critical health challenges through the development of novel antitumor and antiviral agents. As research continues to evolve, Hummel's contributions remain integral to advancements in therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…